Hanger Clinic | |
220 Farmington Avenue, Suite 104, Farmington, Connecticut 06032 | |
(860) 678-7233 |
Name | Hanger Clinic |
---|---|
Organization Name | Hanger Prosthetics & Orthotics Inc |
Location | 220 Farmington Avenue, Suite 104, Farmington, Connecticut 06032 |
Type | Durable Medical Equipment & Medical Supplies Supplier |
Phone | (860) 678-7233 |
Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
FDB announced a strategic partnership with OXGENE™, an industry leader in the design and development of gene therapy technologies.
Improving the health of the deaf and hard-of-hearing population through accessible patient-reported outcome measures is the goal of a $1.6 million National Institutes of Health-funded study, led by Rochester Institute of Technology.
Meridian Bioscience, Inc., Cincinnati, Ohio today announced that it has received clearance from the U.S. Food and Drug Administration for a new pediatric claim for its illumigene C. difficile molecular amplification test. C. difficile is a bacterium that is frequently associated with antibiotic therapy often causing diarrhea and, in severe cases, a life-threatening inflammation of the colon.
For men with advanced prostate cancer that has progressed after taking hormones and undergoing chemotherapy, getting an accurate prognosis is critical to determine the next steps for treatment.
MedAvante, Inc., the leader in centralized expert evaluation of treatments for central nervous system disorders, announced that Cipher Pharmaceuticals is using MedAvante Centralized Ratings in their pivotal Phase 3 dermatology study.
› Verified 4 days ago
NPI Number | 1619041761 |
Organization Name | HANGER PROSTHETICS & ORTHOTICS INC |
Doing Business As | HANGER CLINIC |
Type | Durable Medical Equipment & Medical Supplies Supplier |
Address | 220 Farmington Ave Ste 104, Farmington, CT 06032 |
Phone Number | 860-678-7233 |
News Archive
FDB announced a strategic partnership with OXGENE™, an industry leader in the design and development of gene therapy technologies.
Improving the health of the deaf and hard-of-hearing population through accessible patient-reported outcome measures is the goal of a $1.6 million National Institutes of Health-funded study, led by Rochester Institute of Technology.
Meridian Bioscience, Inc., Cincinnati, Ohio today announced that it has received clearance from the U.S. Food and Drug Administration for a new pediatric claim for its illumigene C. difficile molecular amplification test. C. difficile is a bacterium that is frequently associated with antibiotic therapy often causing diarrhea and, in severe cases, a life-threatening inflammation of the colon.
For men with advanced prostate cancer that has progressed after taking hormones and undergoing chemotherapy, getting an accurate prognosis is critical to determine the next steps for treatment.
MedAvante, Inc., the leader in centralized expert evaluation of treatments for central nervous system disorders, announced that Cipher Pharmaceuticals is using MedAvante Centralized Ratings in their pivotal Phase 3 dermatology study.
› Verified 4 days ago
News Archive
FDB announced a strategic partnership with OXGENE™, an industry leader in the design and development of gene therapy technologies.
Improving the health of the deaf and hard-of-hearing population through accessible patient-reported outcome measures is the goal of a $1.6 million National Institutes of Health-funded study, led by Rochester Institute of Technology.
Meridian Bioscience, Inc., Cincinnati, Ohio today announced that it has received clearance from the U.S. Food and Drug Administration for a new pediatric claim for its illumigene C. difficile molecular amplification test. C. difficile is a bacterium that is frequently associated with antibiotic therapy often causing diarrhea and, in severe cases, a life-threatening inflammation of the colon.
For men with advanced prostate cancer that has progressed after taking hormones and undergoing chemotherapy, getting an accurate prognosis is critical to determine the next steps for treatment.
MedAvante, Inc., the leader in centralized expert evaluation of treatments for central nervous system disorders, announced that Cipher Pharmaceuticals is using MedAvante Centralized Ratings in their pivotal Phase 3 dermatology study.
› Verified 4 days ago
Arrow Prescription Center #15, Inc. Type: Durable Medical Equipment & Medical Supplies Supplier Location: 263 Farmington Ave, Farmington, Connecticut 06030 Phone: (860) 679-5262 | |
Better Health Llc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 234 Main St, Farmington, Connecticut 06032 Phone: (860) 676-2969 | |
Cvs Pharmacy #000145 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 330 Main Street, Farmington, Connecticut 06032 Phone: (860) 677-5047 | |
Hanger Clinic Type: Durable Medical Equipment & Medical Supplies Supplier Location: 220 Farmington Avenue, Farmington, Connecticut 06032 Phone: (860) 678-7233 | |
Hanger Clinic Type: Durable Medical Equipment & Medical Supplies Supplier Location: 399 Farmington Ave, Farmington, Connecticut 06032 Phone: (860) 837-9273 |